Science News
from research organizations

Combined Molecular-targeted And Hormonal Therapies Offer Promise In Treating Ovarian Cancer

Date:
May 9, 2007
Source:
Blackwell Publishing Ltd.
Summary:
A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review.
Share:
       
FULL STORY

A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.

“Several clinical trials have confirmed the role of hormone therapy in recurrent ovarian cancer treatment, especially in patients with low-grade tumors,” says review author Dr. Siqing Fu, an assistant professor of oncology at the University of Texas at Houston. “However, more research is needed to determine whether combining molecular-targeted therapy with hormonal therapy would be a more effective option.”

Ovarian cancer is the deadliest of gynecological cancers; approximately 70 percent of patients are diagnosed in the later stages, when the 5-year survival rate drops below 25 percent. Traditional chemotherapy has proven to be generally ineffective against recurrent ovarian cancer, which has led researchers to investigate novel treatments.

“While a cure is unlikely, the goals of treatment are to control tumor-related symptoms and to improve or maintain quality of life,” says Dr. Fu. “After surveying the latest research, combined molecular-targeted and hormonal therapy offers the greatest promise in achieving these goals and therefore deserves further investigation.”


Story Source:

The above post is reprinted from materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "Combined Molecular-targeted And Hormonal Therapies Offer Promise In Treating Ovarian Cancer." ScienceDaily. ScienceDaily, 9 May 2007. <www.sciencedaily.com/releases/2007/05/070508185853.htm>.
Blackwell Publishing Ltd.. (2007, May 9). Combined Molecular-targeted And Hormonal Therapies Offer Promise In Treating Ovarian Cancer. ScienceDaily. Retrieved August 2, 2015 from www.sciencedaily.com/releases/2007/05/070508185853.htm
Blackwell Publishing Ltd.. "Combined Molecular-targeted And Hormonal Therapies Offer Promise In Treating Ovarian Cancer." ScienceDaily. www.sciencedaily.com/releases/2007/05/070508185853.htm (accessed August 2, 2015).

Share This Page: